updates in mds diagnosis and prognosis with the ipss-m: personalized medicine in 2023
Published 4 months ago • 82 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
2:48
validation of iwg 2023 criteria for response to treatment with hma in hr-mds
-
1:35
ipss-m: prognostic power in hma-treated mds patients
-
1:55
mds genomics: diagnosis and prognosis
-
1:26
current and emerging prognostic factors for mds/mpn
-
2:43
novel therapies in the future of mds treatment
-
1:39
ipss-r vs ipss-m for mds
-
1:29:13
myelodysplastic syndrome
-
4:28
understanding myelodysplastic syndromes (mds)
-
4:48
managing and treating mds
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
3:31
relevance of the ipss-r during sct in patients with mds in the molecular classification era
-
4:01
the latest genomic updates in the field of mds
-
1:45
updates on the treatment of mds
-
3:58
prognosis & advances in treatment strategies for sf3b1-mutant mds
-
2:37
evidence supporting mrd-guided treatment breaks in mm
-
2:14
trial updates for luspatercept in lr-mds: commands, medalist and elements-mds
-
1:25
prognosis and treatment in high-risk mds
-
4:08
personalization of care for mds patients
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis